BACKGROUND & AIMS: Premature neonates are predisposed to necrotizing enterocolitis (NEC), an idiopathic, inflammatory bowel necrosis. We investigated whether NEC occurs in the preterm intestine due to incomplete noninflammatory differentiation of intestinal macrophages, which increases the risk of a severe mucosal inflammatory response to bacterial products. METHODS: We compared inflammatory properties of human/murine fetal, neonatal, and adult intestinal macrophages. To investigate gut-specific macrophage differentiation, we next treated monocyte-derived macrophages with conditioned media from explanted human fetal and adult intestinal tissues. Transforming growth factor-β (TGF-β) expression and bioactivity were measured in fetal/adult intestine and in NEC. Finally, we used wild-type and transgenic mice to investigate the effects of deficient TGF-β signaling on NEC-like inflammatory mucosal injury. RESULTS: Intestinal macrophages in the human preterm intestine (fetus/premature neonate), but not in full-term neonates and adults, expressed inflammatory cytokines. Macrophage cytokine production was suppressed in the developing intestine by TGF-β, particularly the TGF-β(2) isoform. NEC was associated with decreased tissue expression of TGF-β(2) and decreased TGF-β bioactivity. In mice, disruption of TGF-β signaling worsened NEC-like inflammatory mucosal injury, whereas enteral supplementation with recombinant TGF-β(2) was protective. CONCLUSIONS: Intestinal macrophages progressively acquire a noninflammatory profile during gestational development. TGF-β, particularly the TGF-β(2) isoform, suppresses macrophage inflammatory responses in the developing intestine and protects against inflammatory mucosal injury. Enterally administered TGF-β(2) protected mice from experimental NEC-like injury.
BACKGROUND & AIMS: Premature neonates are predisposed to necrotizing enterocolitis (NEC), an idiopathic, inflammatory bowel necrosis. We investigated whether NEC occurs in the preterm intestine due to incomplete noninflammatory differentiation of intestinal macrophages, which increases the risk of a severe mucosal inflammatory response to bacterial products. METHODS: We compared inflammatory properties of human/murine fetal, neonatal, and adult intestinal macrophages. To investigate gut-specific macrophage differentiation, we next treated monocyte-derived macrophages with conditioned media from explanted human fetal and adult intestinal tissues. Transforming growth factor-β (TGF-β) expression and bioactivity were measured in fetal/adult intestine and in NEC. Finally, we used wild-type and transgenic mice to investigate the effects of deficient TGF-β signaling on NEC-like inflammatory mucosal injury. RESULTS: Intestinal macrophages in the human preterm intestine (fetus/premature neonate), but not in full-term neonates and adults, expressed inflammatory cytokines. Macrophage cytokine production was suppressed in the developing intestine by TGF-β, particularly the TGF-β(2) isoform. NEC was associated with decreased tissue expression of TGF-β(2) and decreased TGF-β bioactivity. In mice, disruption of TGF-β signaling worsened NEC-like inflammatory mucosal injury, whereas enteral supplementation with recombinant TGF-β(2) was protective. CONCLUSIONS: Intestinal macrophages progressively acquire a noninflammatory profile during gestational development. TGF-β, particularly the TGF-β(2) isoform, suppresses macrophage inflammatory responses in the developing intestine and protects against inflammatory mucosal injury. Enterally administered TGF-β(2) protected mice from experimental NEC-like injury.
Authors: Lesley E Smythies; Akhil Maheshwari; Ronald Clements; Devin Eckhoff; Lea Novak; Huong L Vu; L Meg Mosteller-Barnum; Marty Sellers; Phillip D Smith Journal: J Leukoc Biol Date: 2006-07-20 Impact factor: 4.962
Authors: Cynthia L Leaphart; Jaime Cavallo; Steven C Gribar; Selma Cetin; Jun Li; Maria F Branca; Theresa D Dubowski; Chhinder P Sodhi; David J Hackam Journal: J Immunol Date: 2007-10-01 Impact factor: 5.422
Authors: John T Benjamin; Rebekah J Smith; Brian A Halloran; Timothy J Day; David R Kelly; Lawrence S Prince Journal: Am J Physiol Lung Cell Mol Physiol Date: 2006-10-27 Impact factor: 5.464
Authors: Shu-Min Lin; Charles W Frevert; Osamu Kajikawa; Mark M Wurfel; Kimberly Ballman; Stephen Mongovin; Venus A Wong; Amy Selk; Thomas R Martin Journal: Am J Respir Cell Mol Biol Date: 2004-04-01 Impact factor: 6.914
Authors: K Hatsushika; T Hirota; M Harada; M Sakashita; M Kanzaki; S Takano; S Doi; K Fujita; T Enomoto; M Ebisawa; S Yoshihara; H Sagara; T Fukuda; K Masuyama; R Katoh; K Matsumoto; H Saito; H Ogawa; M Tamari; A Nakao Journal: Clin Exp Allergy Date: 2007-08 Impact factor: 5.018
Authors: Kopperuncholan Namachivayam; Hayley P Coffing; Nehru Viji Sankaranarayanan; Yingzi Jin; Krishnan MohanKumar; Brandy L Frost; Cynthia L Blanco; Aloka L Patel; Paula P Meier; Steven A Garzon; Umesh R Desai; Akhil Maheshwari Journal: Am J Physiol Gastrointest Liver Physiol Date: 2015-06-04 Impact factor: 4.052
Authors: Sunil K Jain; Eric W Baggerman; Krishnan Mohankumar; Kopperuncholan Namachivayam; Ramasamy Jagadeeswaran; Victor E Reyes; Akhil Maheshwari Journal: Am J Physiol Gastrointest Liver Physiol Date: 2014-01-09 Impact factor: 4.052
Authors: Timothy L Denning; Amina M Bhatia; Andrea F Kane; Ravi M Patel; Patricia W Denning Journal: Semin Perinatol Date: 2016-12-09 Impact factor: 3.300